Updating the MASH pharmacotherapy landscape: a network meta-analysis incorporating SGLT2 inhibitors and emerging combination therapies - Quiz - MDSpire

Updating the MASH pharmacotherapy landscape: a network meta-analysis incorporating SGLT2 inhibitors and emerging combination therapies

  • By

  • Mengshi Tang

  • Yingxu Ma

  • Yating Wang

  • June 4, 2026

  • 0 min

Share

Original Source(s)

Updating the MASH pharmacotherapy landscape: a network meta-analysis incorporating SGLT2 inhibitors and emerging combination therapies

  • by Mengshi Tang, Yingxu Ma, Yating Wang

  • June 4, 2026

Related Content

Reprogramming of Hepatic Antigen Presenting Cells Through Epigenetic Mechanisms in Chronic Liver Disease

Familial Hypobetalipoproteinemia as a Frequently Overlooked Factor in Pediatric Fatty Liver Disease

Deep learning reconstruction improves detection of focal liver lesions in hepatobiliary phase compared to conventional EOB-MRI